Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker

Thioredoxin interacting protein (TXNIP) is a metabolic protein critically involved in redox homeostasis and has been proposed as a tumor suppressor gene in a variety of malignancies. Accordingly, TXNIP is downregulated in breast, bladder, and gastric cancer and in tumor transplant models TXNIP overe...

Full description

Bibliographic Details
Main Authors: Joana Schröder, Udo Schumacher, Lukas Clemens Böckelmann
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/10/3028
_version_ 1797550619768127488
author Joana Schröder
Udo Schumacher
Lukas Clemens Böckelmann
author_facet Joana Schröder
Udo Schumacher
Lukas Clemens Böckelmann
author_sort Joana Schröder
collection DOAJ
description Thioredoxin interacting protein (TXNIP) is a metabolic protein critically involved in redox homeostasis and has been proposed as a tumor suppressor gene in a variety of malignancies. Accordingly, TXNIP is downregulated in breast, bladder, and gastric cancer and in tumor transplant models TXNIP overexpression inhibits growth and metastasis. As TXNIP protein expression has only been investigated in few malignancies, we employed immunohistochemical detection in a large multi-tumor tissue microarray consisting of 2,824 samples from 94 different tumor entities. In general, TXNIP protein was present only in a small proportion of primary tumor samples and in these cases was differently expressed depending on tumor stage and subtype (e.g., renal cell carcinoma, thyroid cancer, breast cancer, and ductal pancreatic cancer). Further, TXNIP protein expression was determined in primary mouse xenograft tumors derived from human cancer cell lines and was immunohistochemically absent in all xenograft tumors investigated. Intriguingly, TXNIP expression became gradually lower in the proximity of the primary tumor tissue and was absent in leukocytes directly adjacent to tumor tissue. In conclusion, these findings suggest that TXNIP downregulation is as a common feature in human tumor xenograft models and that intra-tumoral leukocytes down-regulate TXNIP. Hence TXNIP expression might be used to monitor the functional state of tumor-infiltrating leukocytes in tissue sections.
first_indexed 2024-03-10T15:31:53Z
format Article
id doaj.art-d370cd4ca7bd477a898a44aac916a1ad
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T15:31:53Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-d370cd4ca7bd477a898a44aac916a1ad2023-11-20T17:34:47ZengMDPI AGCancers2072-66942020-10-011210302810.3390/cancers12103028Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance MarkerJoana Schröder0Udo Schumacher1Lukas Clemens Böckelmann2Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, GermanyInstitute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, GermanyInstitute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, GermanyThioredoxin interacting protein (TXNIP) is a metabolic protein critically involved in redox homeostasis and has been proposed as a tumor suppressor gene in a variety of malignancies. Accordingly, TXNIP is downregulated in breast, bladder, and gastric cancer and in tumor transplant models TXNIP overexpression inhibits growth and metastasis. As TXNIP protein expression has only been investigated in few malignancies, we employed immunohistochemical detection in a large multi-tumor tissue microarray consisting of 2,824 samples from 94 different tumor entities. In general, TXNIP protein was present only in a small proportion of primary tumor samples and in these cases was differently expressed depending on tumor stage and subtype (e.g., renal cell carcinoma, thyroid cancer, breast cancer, and ductal pancreatic cancer). Further, TXNIP protein expression was determined in primary mouse xenograft tumors derived from human cancer cell lines and was immunohistochemically absent in all xenograft tumors investigated. Intriguingly, TXNIP expression became gradually lower in the proximity of the primary tumor tissue and was absent in leukocytes directly adjacent to tumor tissue. In conclusion, these findings suggest that TXNIP downregulation is as a common feature in human tumor xenograft models and that intra-tumoral leukocytes down-regulate TXNIP. Hence TXNIP expression might be used to monitor the functional state of tumor-infiltrating leukocytes in tissue sections.https://www.mdpi.com/2072-6694/12/10/3028cancerimmunotherapyreactive oxygen speciesthioredoxinthioredoxin interacting proteintissue array
spellingShingle Joana Schröder
Udo Schumacher
Lukas Clemens Böckelmann
Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker
Cancers
cancer
immunotherapy
reactive oxygen species
thioredoxin
thioredoxin interacting protein
tissue array
title Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker
title_full Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker
title_fullStr Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker
title_full_unstemmed Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker
title_short Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker
title_sort thioredoxin interacting protein txnip is differentially expressed in human tumor samples but is absent in human tumor cell line xenografts implications for its use as an immunosurveillance marker
topic cancer
immunotherapy
reactive oxygen species
thioredoxin
thioredoxin interacting protein
tissue array
url https://www.mdpi.com/2072-6694/12/10/3028
work_keys_str_mv AT joanaschroder thioredoxininteractingproteintxnipisdifferentiallyexpressedinhumantumorsamplesbutisabsentinhumantumorcelllinexenograftsimplicationsforitsuseasanimmunosurveillancemarker
AT udoschumacher thioredoxininteractingproteintxnipisdifferentiallyexpressedinhumantumorsamplesbutisabsentinhumantumorcelllinexenograftsimplicationsforitsuseasanimmunosurveillancemarker
AT lukasclemensbockelmann thioredoxininteractingproteintxnipisdifferentiallyexpressedinhumantumorsamplesbutisabsentinhumantumorcelllinexenograftsimplicationsforitsuseasanimmunosurveillancemarker